Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Oct 15;17(20):8018-23.
doi: 10.1523/JNEUROSCI.17-20-08018.1997.

Different mechanisms mediate development and expression of tolerance and dependence for peripheral mu-opioid antinociception in rat

K O Aley  1 , J D Levine
Affiliations

Different mechanisms mediate development and expression of tolerance and dependence for peripheral mu-opioid antinociception in rat

K O Aley et al. J Neurosci. .

Abstract

The mu-opioid [D-Ala2,N-Me-Phe4,Gly-ol5]-enkephalin (DAMGO) exerts a peripheral antinociceptive effect against prostaglandin E2 (PGE2)-induced mechanical hyperalgesia in the hindpaw of the rat. Tolerance and dependence develop to this effect. We have shown previously that tolerance and dependence can be dissociated and are mediated by different second messenger systems. In the present study, we evaluated whether the same or different second messenger systems mediate the development of this peripheral opioid tolerance or dependence compared with the expression of the loss of antinociceptive effect or rebound opioid antagonist hyperalgesia (i. e., expression of tolerance and dependence). DAMGO-induced tolerance was prevented by pretreatment with the nitric oxide synthase inhibitor NG-methyl-L-arginine (NMLA) but not by the protein kinase C (PKC) inhibitor chelerythrine, the adenylyl cyclase inhibitor 2',5'-dideoxyadenosine (ddA), or the calcium chelators 3,4,5-trimethoxybenzoic acid 8-(diethylamino)-octyl ester (TMB-8) and 2-[(2-bis-[carboxymethyl]amino-5-methylphenoxy)-methyl]-6-methoxy-8-bis [carboxymethyl]aminoquinoline (Quin-2). Once established, however, expression of DAMGO tolerance was acutely reversed by TMB-8 or Quin-2 but not by chelerythrine or NMLA. In contrast, naloxone-precipitated hyperalgesia in DAMGO-tolerant paws, a measure of dependence, was blocked by pretreatment with chelerythrine but not by NMLA, ddA, TMB-8, or Quin-2. Naloxone-precipitated hyperalgesia in DAMGO-tolerant paws was acutely reversed by chelerythrine, ddA, TMB-8, or Quin-2 but not by NMLA. Taken together, these results provide the first evidence that different mechanisms mediate the development and expression of both tolerance and dependence to the peripheral antinociceptive effect of DAMGO. However, although the development of tolerance and dependence are entirely separable, the expression of tolerance and dependence shares common calcium-dependent mechanisms.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
A, Role of NO in development of peripheral opioid tolerance. Effects of PGE2 (100 ng;PGE2; n = 16), DAMGO (1 μg) plus PGE2(DAMGO+PGE2; n = 16), three hourly injections of DAMGO followed by DAMGO plus PGE2 at the fourth hour (DAMGO×3,DAMGO+PGE2;n = 12), saline (n = 6), NMLA (1 μg) plus PGE2(NMLA+PGE2; n = 8), NMLA alone (NMLA; n = 6), three hourly injections of NMLA followed by PGE2 at the fourth hour (NMLA×3,PGE2;n = 6), and three hourly injections of NMLA plus DAMGO followed by DAMGO plus PGE2[(NMLA+DAMGO)×3,DAMGO+PGE2;n = 12] on mechanical paw withdrawal threshold in rats. In this and all subsequent figures, an asteriskindicates p < 0.05, and NSindicates not significant statistically. B, Lack of role of PKC in development of peripheral opioid tolerance. Effects of PGE2 (100 ng; PGE2;n = 16), DAMGO (1 μg) plus PGE2(DAMGO+PGE2; n = 16), three hourly injections of DAMGO followed by DAMGO plus PGE2(DAMGO×3,DAMGO+PGE2;n = 12), chelerythrine (1 μg) alone (Ch; n = 6), chelerythrine plus PGE2 (Ch+PGE2;n = 6), chelerythrine plus DAMGO plus PGE2 (Ch+DAMGO+PGE2;n = 6), and three hourly injections of chelerythrine plus DAMGO followed by DAMGO plus PGE2[(Ch+DAMGO)×3,DAMGO+PGE2;n = 6] on mechanical paw withdrawal threshold in rats. C, Lack of role of cAMP in development of peripheral opioid tolerance. Effects of PGE2 (100 ng;PGE2; n = 16), DAMGO (1 μg) plus PGE2(DAMGO+PGE2; n = 16), three hourly injections of DAMGO followed by DAMGO plus PGE2(DAMGO×3,DAMGO+PGE2;n = 12), ddA (1 μg) plus PGE2(ddA+PGE2; n = 6), ddA alone (ddA; n = 6), three hourly injections of ddA followed by PGE2 at the fourth hour (ddA×3,PGE2;n = 6), and three hourly injections of ddA (1 μg) plus DAMGO followed by DAMGO plus PGE2 at the fourth hour [(ddA+DAMGO)×3,DAMGO+PGE2;n = 12] on mechanical paw withdrawal threshold in rats. D, Lack of role of calcium in development of peripheral opioid tolerance. Effect of PGE2 (100 ng;PGE2; n = 16), DAMGO (1 μg) plus PGE2(DAMGO+PGE2; n = 16), three hourly injections of DAMGO followed by DAMGO plus PGE2(DAMGO×3,DAMGO+PGE2;n = 12), TMB-8 (1 μg) alone (TMB;n = 6), TMB-8 plus PGE2, (TMB+PGE2; n = 6), TMB-8 plus DAMGO plus PGE2(TMB+DAMGO+PGE2;n = 6), and three hourly injections of TMB-8 plus DAMGO followed by DAMGO plus PGE2 at the fourth hour [(TMB+DAMGO)×3,DAMGO+PGE2;n = 6] on mechanical paw withdrawal threshold in rats. E, Lack of role of calcium in development of peripheral opioid tolerance. Effects of PGE2 (100 ng;PGE2; n = 16), DAMGO (1 μg) plus PGE2(DAMGO+PGE2; n = 16), three hourly injections of DAMGO followed by DAMGO plus PGE2(DAMGO×3,DAMGO+PGE2;n = 12), Quin-2 (1 μg) alone (Quin; n = 6), Quin-2 plus PGE2 (Quin+PGE2;n = 6), Quin-2 plus DAMGO plus PGE2(Quin+DAMGO+PGE2;n = 6), and three hourly injections of Quin-2 plus DAMGO followed by DAMGO plus PGE2 at the fourth hour [(Quin+DAMGO)×3,DAMGO+PGE2;n = 6] on mechanical paw withdrawal threshold in rats.
Fig. 2.
Fig. 2.
Calcium but not PKC or NO plays a role in the expression of peripheral opioid tolerance. Effects of PGE2, (PGE2;n = 16), DAMGO plus PGE2(DAMGO+PGE2; n = 16), three hourly injections of DAMGO followed by DAMGO plus PGE2(DAMGO×3, DAMGO+PGE2;n = 12), three hourly injections of DAMGO followed by TMB-8 plus DAMGO plus PGE2 at the fourth hour (DAMGO×3,TMB+DAMGO+PGE2;n = 6), three hourly injections of DAMGO followed by Quin-2 plus DAMGO plus PGE2 at the fourth hour (DAMGO×3,Quin+DAMGO+PGE2;n = 6), three hourly injections of DAMGO followed by chelerythrine plus DAMGO plus PGE2 at the fourth hour (DAMGO×3,Ch+DAMGO+PGE2;n = 12), and three hourly injections of DAMGO followed by NMLA plus DAMGO plus PGE2 at the fourth hour (DAMGO×3,NMLA+DAMGO+PGE2;n = 6) on mechanical paw withdrawal threshold in rats.
Fig. 3.
Fig. 3.
PKC but not NO, cAMP, or calcium plays a role in the development of peripheral opioid dependence. Effects of PGE2, (PGE2;n = 16), DAMGO plus PGE2(DAMGO+PGE2; n = 16), three hourly injections of DAMGO followed by vehicle at the fourth hour (DAMGO×3,V; n = 6), three hourly injections of DAMGO followed by naloxone at the fourth hour (DAMGO×3,NAL; n = 12), three hourly injections of chelerythrine plus DAMGO followed by naloxone at the fourth hour [(Ch+DAMGO)×3,NAL; n = 6], three hourly injections of NMLA plus DAMGO followed by naloxone at the fourth hour [(NMLA+DAMGO)×3,NAL;n = 12], three hourly injections of ddA plus DAMGO followed by naloxone at the fourth hour [(ddA+DAMGO)×3,NAL; n = 6], three hourly injections of TMB-8 plus DAMGO followed by naloxone at the fourth hour [(TMB+DAMGO)×3,NAL; n= 6], and three hourly injections of chelerythrine plus DAMGO followed by naloxone at the fourth hour [(Quin+DAMGO)×3,NAL;n = 6] on mechanical paw withdrawal threshold in rats.
Fig. 4.
Fig. 4.
PKC, calcium, and cAMP, but not NO, play a role in expression of peripheral opioid dependence. Effects of PGE2(PGE2; n = 16), DAMGO plus PGE2(DAMGO+PGE2; n = 16), three hourly injections of DAMGO followed by naloxone at the fourth hour (DAMGO×3,NAL; n = 12), three hourly injections of DAMGO followed by chelerythrine plus naloxone at the fourth hour (DAMGO×3,Ch+NAL;n = 10), three hourly injections of DAMGO followed by ddA plus naloxone at the fourth hour (DAMGO×3,ddA+NAL; n = 6), three hourly injections of DAMGO followed by TMB-8 plus naloxone at the fourth hour (DAMGO×3,TMB+NAL; n = 12), three hourly injections of DAMGO followed by Quin-2 plus naloxone at the fourth hour (DAMGO×3, Quin+NAL; n= 12), and three hourly injections of DAMGO followed by NMLA plus naloxone at the fourth hour (DAMGO×3,NMLA+NAL;n = 8) on mechanical paw withdrawal threshold in rats.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Adams ML, Kalicki JM, Meyer ER, Cicero TJ. Inhibition of the morphine withdrawal syndrome by a nitric oxide synthase inhibitor, NG-nitro-l-arginine methyl ester. Life Sci. 1993;52:PL245–PL249. - PubMed
    1. Aley KO, Levine JD. Multiple receptors involved in peripheral α2, μ, and A1 antinociception, tolerance, and withdrawal. J Neurosci. 1997a;17:735–744. - PMC - PubMed
    1. Aley KO, Levine JD. Dissociation of tolerance and dependence for opioid peripheral antinociception in rats. J Neurosci. 1997b;17:3907–3912. - PMC - PubMed
    1. Aley KO, Green PG, Levine JD. Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal. J Neurosci. 1995;15:8031–8038. - PMC - PubMed
    1. Alkon DL, Kubota M, Neary JT, Naito S, Coulter D, Ramussen H. C-kinase activation prolongs CA++-dependent inactivation of K+ currents. Biochem Biophys Res Commun. 1986;134:1245–1253. - PubMed

Publication types